4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000048
CEO bought 114,000 shares at an average $0.01 ($1,113)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-30 | Purchase : show line 1 in the form | +2,000 | $0.01 | $20 | 25,186,297 | D |
| 2019-08-30 | Purchase : show line 2 in the form | +2,000 | $0.01 | $20 | 25,188,297 | D |
| 2019-08-30 | Purchase : show line 3 in the form | +5,000 | $0.01 | $52 | 25,193,297 | D |
| 2019-09-03 | Purchase : show line 4 in the form | +5,000 | $0.01 | $51 | 25,198,297 | D |
| 2019-09-04 | Purchase : show line 5 in the form | +5,000 | $0.01 | $55 | 25,203,297 | D |
| 2019-09-04 | Purchase : show line 6 in the form | +5,000 | $0.01 | $50 | 25,208,297 | D |
| 2019-09-04 | Purchase : show line 7 in the form | +15,000 | $0.01 | $150 | 25,223,297 | D |
| 2019-09-04 | Purchase : show line 8 in the form | +5,000 | $0.01 | $50 | 25,228,297 | D |
| Open-market purchases · 114,000 sh · avg $0.01 · $1,113 | ||||||
Loading xslF345X03/primary_doc.xml…